Analysts speculate that Swiss drugmaker Roche may pay up to $10bn to buy rest of Chugai, even as Japanese group denied it was reviewing such a plan
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com